Annovis Bio, Inc. (ANVS) — Financial statements
Income statement, balance sheet, and cash flow for Annovis Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 25,216↑126006.7% | 20↓48.5% | 39↑134.9% | 17↑94.8% | 8 | |
| General & Administrative Expenses | 4,480↑66765.6% | 7↑7.3% | 6↓30.6% | 9↑48.5% | 6 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 4,480↑66765.6% | 7↑7.3% | 6↓30.6% | 9↑48.5% | 6 | |
| Other Expenses | -29,666 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 30↑11.2% | 27↓40.7% | 45↑76.5% | 26↑75.5% | 15 | |
| Total Costs & Expenses | 30↑11.2% | 27↓40.7% | 45↑76.5% | 26↑75.5% | 15 | |
| Operating Results | ||||||
| Operating Income | -30↓11.2% | -27↑40.7% | -45↓76.5% | -26↓75.5% | -15 | |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBITDA | -30↓11.2% | -27↑40.7% | -45↓76.5% | -26↓75.9% | -15 | |
| EBIT | -30↓11.2% | -27↑40.7% | -45↓76.5% | -26↓75.9% | -15 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.70↑146.0% | -2↓327.8% | 0.67↑265.5% | 0.18↑1270.2% | 0.01 | |
| Interest Income | 0.70↑110.7% | 0.33↓50.3% | 0.67↑265.5% | 0.18↑1270.2% | 0.01 | |
| Interest Expense | 0.00↓100.0% | 2 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.04 | |
| Other Income / Expenses | 0.84↓60.0% | 2↑118.8% | -11↓6212.9% | 0.18↑264.8% | 0.05 | |
| Income Before Tax | -29↓17.3% | -25↑56.2% | -56↓121.9% | -25↓74.8% | -14 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -29↓17.3% | -25↑56.2% | -56↓121.9% | -25↓74.8% | -14 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -29↓17.3% | -25↑56.2% | -56↓121.9% | -25↓74.8% | -14 | |
| Bottom-Line Net Income | -29↓2.3% | -28↑49.8% | -56↓121.9% | -25↓74.8% | -14 | |
| EPS (Basic) | -1.40↑99.9% | -2,018.50↓32299.7% | -6.23↓101.0% | -3.10↓63.2% | -1.90 | |
| EPS (Diluted) | -1.40↑99.9% | -2,009.77↓32159.6% | -6.23↓101.0% | -3.10↓63.2% | -1.90 | |
| Weighted Average Shares | 21↑68.7% | 12↑35.0% | 9↑10.5% | 8↑7.0% | 8 | |
| Weighted Average Diluted Shares | 21↑68.0% | 12↑35.6% | 9↑10.5% | 8↑7.0% | 8 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.